- Merz invested 15 million Euros in a new filler plant in Dessau.
- Oncotec invested 35 million Euros in new installations at its Dessau site.
- Merz's new plant spans 1,200 square meters and employs about 150 people.
- Oncotec unveiled a robot-controlled filling line and automatic syringe inspection system.
Merz's New Filler Plant
Merz has officially opened a new filler plant in BioPharmaPark, Dessau-Rosslau, Germany. This new facility was constructed to meet the growing global demand for Belotero® dermal fillers. The plant represents a 15 million Euro investment and covers 1,200 square meters across three floors. Approximately 150 employees are currently working at Merz's Dessau site.
Oncotec's Investment and New Installations
Oncotec, a subsidiary of medac, is celebrating 22 years of pharmaceutical production in Dessau with a new 35 million Euro investment at its BioPharmaPark site. The company specializes in the production and development of liquid cytostatics, particularly for cancer and autoimmune diseases. Oncotec has unveiled a robot-controlled filling line and a fully automatic visual inspection system for syringes.
Strategic Importance
Philip Burchard, CEO of Merz, emphasized the strategic importance of the new plant, which will help meet the increasing demand for their dermal fillers. The facility is built to the highest international standards, ensuring premium production quality under clean room conditions.
Commitment to Quality
Dr. Torsten Wagner, Senior Vice President Global Technical Operations at Merz, highlighted the company's continuous investment in the Dessau site since its first production facility opened in 2002. This ongoing commitment ensures the highest quality, safety, and technology standards in line with Merz's growth plans.
Future Readiness
Maren Michel, Managing Director of Oncotec, stated that the new installations position the company to meet future demands and dynamic global developments in drug manufacturing. Jörg Hans, CEO of medac, noted that these investments are beneficial for the 306 employees at Oncotec and the Dessau site.
